On September 4, 2025, TNF Pharmaceuticals, Inc. reported the closing of a private placement, selling 7,000 shares of Series H Convertible Preferred Stock and acquiring 100% of LPU Holdings LLC for shares convertible to 747,362 common stock. The event is significant and has a neutral sentiment for investors.